However, studies have suggested that ALL patients with MTHFR C677T mutant types (CT/TT) were more sensitive to HD-MTX chemotherapy and at a higher risk of toxicities compared with individuals with the wild-type mutant (CC) [12,13,14,22,28,29]. The gene discussed is MTHFR; the disease is acute lymphoblastic leukemia.